Records containing: Squamous Cell Carcinoma of the Anal Canal
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-03-06Towards an Understanding of Barriers and Delays in the Diagnosis of Anal Cancer
-
CLINICAL_TRIALS study record update · 2026-01-08An Early Access Program Guideline to Provide Access to Retifanlimab (INCMGA00012) Together With Carboplatin and Paclitaxel for Squamous Carcinoma of the Anal Canal (SCAC)
-
CLINICAL_TRIALS study record update · 2025-05-23A Phase 3 Global, Multicenter, Double-Blind Randomized Study of Carboplatin-Paclitaxel With INCMGA00012 or Placebo in Participants With Inoperable Locally Recurrent or Metastatic Squamous Cell Carcinoma of the Anal Canal Not Previously Treated With Systemic Chemotherapy (POD1UM-303/InterAACT 2)
-
CLINICAL_TRIALS study record update · 2023-09-13Phase II Study of Atezolizumab Plus Tiraglolumab in Combination With Chemoradiotherapy in Localized Squamous Cell Carcinoma of the Anal Canal
-
CLINICAL_TRIALS study record update · 2023-04-27Tumor Recurrence After Abdominal-perineal Amputation in Squamous Cell Carcinoma of the Anus
- Organize your saved records without ads with Plus.